[Comment] Fibroblast growth factor 21 for non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis is a form of fatty liver disease that is characterised by hepatic necroinflammation, progression of fibrosis, and a strong association with metabolic syndrome, and is increasing as a cause of morbidity and mortality. In the USA alone, 27 million people are anticipated to have non-alcoholic steatohepatitis by 2030, which is expected to cause 105 430 cases of decompensated cirrhosis, 12 240 cases of hepatocellular carcinoma, and 78 300 deaths from liver-associated causes annually.

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2UIaaac
via IFTTT